Tom Connors (research scientist)

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Tom Connors" research scientist – news · newspapers · books · scholar · JSTOR (July 2015) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Tom Connors" research scientist – news · newspapers · books · scholar · JSTOR (July 2015) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Professor Thomas Anthony Connors (18 December 1934 – 4 February 2002) was a British cancer research scientist.^[1]

Connors was for 40 years involved in the development of anti-cancer drugs including

. Connors was awarded many honours including honorary degrees from several universities, Including Aston (1997)^[4] and Dublin Trinity in 2001.^[5] He has a research unit named after him at Bradford University.^[6]

Tom Connors was an alumnus of Wimbledon College, to which he won a scholarship to study in the 1940s/50's. As well as proving to be an adept academic, he represented the school at rugby where he played wing three-quarter and went on to play many times for the Old Wimbledonians rugby club. He also represented the school and London schools at athletics, being at the time one of the fastest boys over 100 yards in the country. Tom was also an active member of the Old Wimbledonians Association.

References